Haematology

Stephen Schey image

Professor Stephen Schey

Consultant Haematologist
Qualifications:

MB BS; FRCP; FRCPath; FRACP

GMC No. or equivalent

1727618

Primary speciality:

Haematology

Specialist interests:

Immunosecretory disease
Myeloma
Waldenstrom’s macroglobulinaemia
Castleman’s disease
POEMS amyloidosis

Professional memberships:

UK Myeloma Forum
British Society of Haematology
National Cancer Research Institute (NCRI)
NCRI Haematology Clinical Specialty Group
American Society of Haematology Scientific Sub-Committee for Immunosecretory Disorders

PA name:

Michelle Salton

Telephone:

+44 (0)20 7234 2002

Consulting address:

Guthrie Clinic
King's College Hospital
NHS Foundation Trust
Denmark Hill
London SE5 9RS

Clinic times:

By appointment

Biography

Professor Schey is a Consultant Haematologist and the myeloma lead with a specialist interest in plasma cell disorders and Immunosecretory disease such as myeloma, Waldenstrom’s Macroglobulinaemia and Castleman’s Disease.

After qualifying at St George’s Hospital he travelled to Australia and worked as Clinical Lecturer in the Institute of Clinical Pathology and Medical Research, Sydney. He returned to work at the Royal Free Hospital as Transplant Co-ordinator before becoming Transplant Co-ordinator at the Royal Marsden Hospital. Upon completing his Haematology training at the Middlesex Hospital the then took up a consultant post at Guy’s Hospital and served as Director of Clinical Haematology from 1993-2004 before moving to King’s College Hospital in 2005.

Prof Schey was the past Secretary and Chairman of the UK Myeloma Forum. He is the Research Lead for the SE Thames Cancer Network; a member of the National Cancer Research Institute (NCRI)Haemoncology Cancer Steering Group and the NCRI Industry Adoption Panel. He also has an interest in clinical trials, having been Chief Investigator and Co-investigator for many clinical trials and is the past Chairman of the NCRI Myeloma Clinical Trials Committee. His interest is in the optimal application of novel therapies and immune treatment of myeloma and associated plasma cell dyscrasias. He has combined an interest in service delivery with clinical research and is currently the President of the British Society for Haematology and the Lead Clinician at King's College Hospital for Clinical Myeloma and Translational Research.

2016 - 2017 © King's College Hospital NHS Foundation Trust